“An Unbelievable Injustice”: Mahvash Sabet and Fariba Kamalabadi sentenced to a second decade in prison in Iran Read more
Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth Read more
Roche’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition Read more
Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI®▼ (teclistamab) in Combination with DARZALEX® (daratumumab) Subcutaneous (SC) Formulation and Lenalidomide in Relapsed or Refractory Multiple Myeloma Read more
Janssen Presents New Data for Talquetamab, a GPRC5DxCD3 Bispecific Antibody, Showing Durable Responses in Patients with Heavily Pretreated Multiple Myeloma Read more
The Partnership for a Drug-Free New Jersey Addresses Surging Substance Use-Related Deaths Among Older Adults Read more
SOC (Spin on Carbon) Hardmasks (COVID-19) to Witness Astonishing Growth by Forecast 2022-2030 | JC Market Research Read more